Annual Long Term Debt
$5.75 M
-$4.58 M-44.32%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual long term debt is currently $5.75 million, with the most recent change of -$4.58 million (-44.32%) on 31 December 2023. During the last 3 years, it has fallen by -$442.18 million (-98.72%). LGND annual long term debt is now -99.11% below its all-time high of $648.93 million, reached on 31 December 2019.LGND Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$6.27 M
-$148.00 K-2.31%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly long term debt is currently $6.27 million, with the most recent change of -$148.00 thousand (-2.31%) on 30 September 2024. Over the past year, it has increased by +$435.00 thousand (+7.46%). LGND quarterly long term debt is now -99.03% below its all-time high of $648.93 million, reached on 31 December 2019.LGND Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.3% | +7.5% |
| 3 y3 years | -98.7% | -98.1% |
| 5 y5 years | -99.1% | -99.0% |
LGND Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.7% | at low | -98.1% | +20.7% |
| 5 y | 5 years | -99.1% | at low | -99.0% | +20.7% |
| alltime | all time | -99.1% | +817.9% | -99.0% | +3543.6% |
Ligand Pharmaceuticals Incorporated Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.27 M(-2.3%) |
| June 2024 | - | $6.42 M(+23.6%) |
| Mar 2024 | - | $5.19 M(-9.8%) |
| Dec 2023 | $5.75 M(-44.3%) | $5.75 M(-1.3%) |
| Sept 2023 | - | $5.83 M(-46.9%) |
| June 2023 | - | $10.99 M(-1.7%) |
| Mar 2023 | - | $11.18 M(+8.2%) |
| Dec 2022 | $10.34 M(-96.8%) | $10.34 M(-70.4%) |
| Sept 2022 | - | $34.89 M(+28.8%) |
| June 2022 | - | $27.09 M(-86.0%) |
| Mar 2022 | - | $193.30 M(-40.2%) |
| Dec 2021 | $322.97 M(-27.9%) | $322.97 M(-1.6%) |
| Sept 2021 | - | $328.36 M(+2.6%) |
| June 2021 | - | $320.09 M(-10.7%) |
| Mar 2021 | - | $358.39 M(-20.0%) |
| Dec 2020 | $447.94 M(-31.0%) | $447.94 M(-2.4%) |
| Sept 2020 | - | $458.89 M(+0.0%) |
| June 2020 | - | $458.85 M(+1.1%) |
| Mar 2020 | - | $453.66 M(-30.1%) |
| Dec 2019 | $648.93 M(+6.4%) | $648.93 M(+1.2%) |
| Sept 2019 | - | $641.47 M(+1.1%) |
| June 2019 | - | $634.70 M(+2.9%) |
| Mar 2019 | - | $616.99 M(+1.2%) |
| Dec 2018 | $609.86 M(+211.3%) | $609.86 M(+1.2%) |
| Sept 2018 | - | $602.84 M(+1.2%) |
| June 2018 | - | $595.91 M(+191.2%) |
| Mar 2016 | - | $204.65 M(+0.8%) |
| Sept 2015 | - | $202.95 M(+1.2%) |
| June 2015 | - | $200.57 M(+1.2%) |
| Mar 2015 | - | $198.22 M(+1.2%) |
| Dec 2014 | $195.91 M(+1357.3%) | $195.91 M(+1.2%) |
| Sept 2014 | - | $193.63 M(+9729.0%) |
| June 2013 | - | $1.97 M(-64.1%) |
| Mar 2013 | - | $5.49 M(-59.1%) |
| Dec 2012 | $13.44 M(-33.7%) | $13.44 M(-44.9%) |
| Sept 2012 | - | $24.41 M(-38.0%) |
| June 2012 | - | $39.39 M(+15.3%) |
| Mar 2012 | - | $34.15 M(+68.3%) |
| Dec 2011 | $20.29 M(-44.1%) | $20.29 M(-59.4%) |
| Sept 2011 | - | $49.99 M(+66.8%) |
| June 2011 | - | $29.98 M(-2.0%) |
| Mar 2011 | - | $30.58 M(+6.8%) |
| Sept 2010 | - | $28.62 M(-2.6%) |
| June 2010 | - | $29.39 M(-14.4%) |
| Mar 2010 | - | $34.34 M(-5.3%) |
| Dec 2009 | $36.27 M(-27.0%) | $36.27 M(-20.1%) |
| Sept 2009 | - | $45.37 M(-1.7%) |
| June 2009 | - | $46.17 M(-1.5%) |
| Mar 2009 | - | $46.86 M(-5.7%) |
| Dec 2008 | $49.70 M(+7827.0%) | $49.70 M(>+9900.0%) |
| Sept 2008 | - | $172.00 K(-35.3%) |
| June 2008 | - | $266.00 K(-34.0%) |
| Mar 2008 | - | $403.00 K(-35.7%) |
| Dec 2007 | $627.00 K | $627.00 K(-29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | $889.00 K(-29.4%) |
| June 2007 | - | $1.26 M(-23.3%) |
| Mar 2007 | - | $1.64 M(-23.9%) |
| Dec 2006 | $2.16 M(-98.7%) | $2.16 M(-98.5%) |
| Sept 2006 | - | $142.07 M(-0.2%) |
| June 2006 | - | $142.31 M(-1.0%) |
| Mar 2006 | - | $143.80 M(-15.5%) |
| Dec 2005 | $170.18 M(-0.5%) | $170.18 M(-0.0%) |
| Sept 2005 | - | $170.19 M(-0.4%) |
| June 2005 | - | $170.83 M(-0.2%) |
| Mar 2005 | - | $171.12 M(+0.0%) |
| Dec 2004 | $171.09 M(+0.6%) | $171.09 M(-0.1%) |
| Sept 2004 | - | $171.26 M(+2.4%) |
| June 2004 | - | $167.26 M(-2.1%) |
| Mar 2004 | - | $170.85 M(+0.5%) |
| Dec 2003 | $170.05 M(+9.5%) | $170.05 M(+9.5%) |
| Sept 2003 | - | $155.25 M(-2.1%) |
| June 2003 | - | $158.65 M(+2.2%) |
| Mar 2003 | - | $155.25 M(0.0%) |
| Dec 2002 | $155.25 M(+13.5%) | $155.25 M(+2101.8%) |
| Sept 2002 | - | $7.05 M(+167.1%) |
| June 2002 | - | $2.64 M(-8.3%) |
| Mar 2002 | - | $2.88 M(-97.9%) |
| Dec 2001 | $136.76 M(+3.8%) | $136.76 M(-0.2%) |
| Sept 2001 | - | $137.06 M(-3.6%) |
| June 2001 | - | $142.17 M(+6.6%) |
| Mar 2001 | - | $133.34 M(+1.2%) |
| Dec 2000 | $131.71 M(-3.7%) | $131.71 M(+9.6%) |
| Sept 2000 | - | $120.20 M(+1.2%) |
| June 2000 | - | $118.72 M(+1.4%) |
| Mar 2000 | - | $117.11 M(-14.3%) |
| Dec 1999 | $136.70 M(+51.0%) | $136.70 M(-11.6%) |
| Sept 1999 | - | $154.60 M(+66.6%) |
| June 1999 | - | $92.80 M(+1.9%) |
| Mar 1999 | - | $91.10 M(+0.7%) |
| Dec 1998 | $90.50 M(+76.1%) | $90.50 M(+82.1%) |
| Sept 1998 | - | $49.70 M(+1.6%) |
| June 1998 | - | $48.90 M(-6.1%) |
| Mar 1998 | - | $52.10 M(+1.4%) |
| Dec 1997 | $51.40 M(-4.8%) | $51.40 M(+3.4%) |
| Sept 1997 | - | $49.70 M(-3.5%) |
| June 1997 | - | $51.50 M(+1.4%) |
| Mar 1997 | - | $50.80 M(-5.9%) |
| Dec 1996 | $54.00 M(+8.2%) | $54.00 M(+12.3%) |
| Sept 1996 | - | $48.10 M(-6.2%) |
| June 1996 | - | $51.30 M(+1.4%) |
| Mar 1996 | - | $50.60 M(+1.4%) |
| Dec 1995 | $49.90 M(+305.7%) | $49.90 M(+0.6%) |
| Sept 1995 | - | $49.60 M(+313.3%) |
| Mar 1995 | - | $12.00 M(-2.4%) |
| Dec 1994 | $12.30 M | $12.30 M(0.0%) |
| Sept 1994 | - | $12.30 M(+434.8%) |
| June 1994 | - | $2.30 M(0.0%) |
| Mar 1994 | - | $2.30 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual long term debt?
- What is the all time high annual long term debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual long term debt year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly long term debt?
- What is the all time high quarterly long term debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual long term debt?
The current annual long term debt of LGND is $5.75 M
What is the all time high annual long term debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual long term debt is $648.93 M
What is Ligand Pharmaceuticals Incorporated annual long term debt year-on-year change?
Over the past year, LGND annual long term debt has changed by -$4.58 M (-44.32%)
What is Ligand Pharmaceuticals Incorporated quarterly long term debt?
The current quarterly long term debt of LGND is $6.27 M
What is the all time high quarterly long term debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly long term debt is $648.93 M
What is Ligand Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
Over the past year, LGND quarterly long term debt has changed by +$435.00 K (+7.46%)